z-logo
open-access-imgOpen Access
Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells
Author(s) -
Alexandre F.S. Queiroz,
Rodrigo A. da Silva,
Raniere M. Moura,
Juliana L. Dreyfuss,
Edgar Julian ParedesGamero,
Ana Carolina Santos de Souza,
Ivarne L.S. Tersariol,
Elizeu Antunes dos Santos,
Helena B. Nader,
Giselle Z. Justo,
Maurı́cio P. Sales
Publication year - 2008
Publication title -
cancer chemotherapy and pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.112
H-Index - 111
eISSN - 1432-0843
pISSN - 0344-5704
DOI - 10.1007/s00280-008-0825-4
Subject(s) - dapi , microbiology and biotechnology , biology , programmed cell death , k562 cells , apoptosis , cytotoxic t cell , cell culture , cathepsin , jurkat cells , cathepsin b , annexin , flow cytometry , cytotoxicity , t cell , biochemistry , immunology , in vitro , immune system , genetics , enzyme
In this study, the antitumoral potential of a novel lectin (CvL) purified from the marine sponge Cliona varians was studied in different cancer cell lines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom